WEC
RMD icon

Winslow Evans & Crocker’s ResMed RMD Stock Holding History

Winslow Evans & Crocker’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$19K Buy
+89
New +$17.7K ﹤0.01% 807

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winslow Evans & Crocker's RMD Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in ResMed (RMD) in Q4 2020: 89 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #807 among its holdings.

663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

  • Winslow Evans & Crocker held 89 shares of ResMed worth $19K as of Q4 2020.
  • ResMed was a new Winslow Evans & Crocker position in Q4 2020.
  • ResMed made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #807 holding.
  • 663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.